[Retrovirus Restriction Factor TRIM5&#945;: The Mechanism of Action and Prospects for Use in Gene Therapy of HIV Infection].

Glazkova, D V; Urusov, F A; Bogoslovskaya, E V; Shipulin, G A

[Retrovirus Restriction Factor TRIM5α: The Mechanism of Action and Prospects for Use in Gene Therapy of HIV Infection].

Glazkova, D V; Urusov, F A; Bogoslovskaya, E V; Shipulin, G A.

Afiliación

Glazkova DV; Center for Strategic Planning and Management of Medical and Biological Health Risks, Federal Medical-Biological Agency of the Russian Federation, Moscow, 119992 Russia.
Urusov FA; Izmerov Research Institute of Occupational Health, Moscow, 105275 Russia.
Bogoslovskaya EV; Center for Strategic Planning and Management of Medical and Biological Health Risks, Federal Medical-Biological Agency of the Russian Federation, Moscow, 119992 Russia.
Shipulin GA; Izmerov Research Institute of Occupational Health, Moscow, 105275 Russia.

Mol Biol (Mosk) ; 54(5): 707-717, 2020.

Article en Ru | MEDLINE | ID: mdl-33009785

Asunto(s)

Terapia Genética; Infecciones por VIH; Proteínas de Motivos Tripartitos/genética; Ubiquitina-Proteína Ligasas/genética; Factores de Restricción Antivirales; Infecciones por VIH/genética; Infecciones por VIH/terapia; Humanos

Palabras clave

HIV-1; TRIM5α; gene therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Terapia Genética / Infecciones por VIH / Ubiquitina-Proteína Ligasas / Proteínas de Motivos Tripartitos Idioma: Ru Revista: Mol Biol (Mosk) Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google